Sanders Morris Harris LLC acquired a new position in Cigna Group (NYSE:CI - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 3,493 shares of the health services provider's stock, valued at approximately $950,000.
Other hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. lifted its stake in shares of Cigna Group by 3.7% in the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider's stock valued at $6,461,457,000 after purchasing an additional 840,098 shares during the last quarter. GQG Partners LLC acquired a new stake in shares of Cigna Group during the 2nd quarter worth about $1,628,918,000. Bank of America Corp DE increased its position in shares of Cigna Group by 8.8% during the 1st quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider's stock worth $848,821,000 after purchasing an additional 256,677 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Cigna Group by 10.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider's stock worth $647,008,000 after purchasing an additional 236,340 shares during the last quarter. Finally, Legal & General Group Plc purchased a new stake in Cigna Group in the 2nd quarter valued at about $542,779,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Cigna Group
In related news, insider Everett Neville sold 617 shares of the business's stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares of the company's stock, valued at $1,435,304.65. The trade was a 10.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,677 shares of the company's stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider owned 25,880 shares in the company, valued at approximately $7,236,306.80. This trade represents a 9.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 22,730 shares of company stock worth $6,293,359. Insiders own 0.60% of the company's stock.
Analysts Set New Price Targets
A number of research analysts have commented on CI shares. Evercore began coverage on shares of Cigna Group in a research report on Wednesday, September 9th. They issued an "in-line" rating and a $290.00 target price on the stock. Barclays lifted their price target on shares of Cigna Group from $304.00 to $310.00 and gave the company an "equal weight" rating in a research report on Friday, July 31st. Wall Street Zen raised shares of Cigna Group from a "hold" rating to a "buy" rating in a research note on Saturday, September 26th. Wells Fargo & Company upped their price objective on shares of Cigna Group from $305.00 to $307.00 and gave the stock an "equal weight" rating in a report on Friday, July 31st. Finally, Weiss Ratings restated a "hold (c)" rating on shares of Cigna Group in a report on Thursday, August 27th. Fifteen research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $338.24.
Check Out Our Latest Stock Analysis on Cigna Group
Cigna Group Trading Up 2.5%
CI traded up $7.04 during mid-day trading on Wednesday, hitting $289.57. 1,396,313 shares of the stock were exchanged, compared to its average volume of 1,671,362. The firm's fifty day moving average is $277.98 and its two-hundred day moving average is $281.41. Cigna Group has a 1-year low of $239.51 and a 1-year high of $311.34. The company has a market cap of $76.52 billion, a PE ratio of 11.98, a PEG ratio of 0.96 and a beta of 0.29. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68.
Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. The company had revenue of $71.56 billion during the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. Cigna Group's revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the company posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities analysts forecast that Cigna Group will post 30.50 earnings per share for the current fiscal year.
Cigna Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th were given a dividend of $1.56 per share. The ex-dividend date of this dividend was Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group's dividend payout ratio is currently 25.82%.
Cigna Group Profile
(
Free Report)
The Cigna Group NYSE: CI is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.
Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.